Items where authors include "Kwan, A."

Article

Kwan, A., Mcdermott-Brown, I. and Muthana, M. orcid.org/0000-0003-2497-8903 (2024) Proliferating cell nuclear antigen in the era of oncolytic virotherapy. Viruses, 16 (8). 1264. ISSN 1999-4915

Collinson, F. orcid.org/0000-0001-6964-6406, Royle, K.-L. orcid.org/0000-0003-0225-1199, Swain, J. orcid.org/0000-0003-2729-3029 et al. (28 more authors) (2024) Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT. Health Technology Assessment, 28 (45). ISSN 1366-5278

Kwan, A., Howard, F. orcid.org/0000-0001-9899-3079, Winder, N. et al. (13 more authors) (2022) Macrophage delivered HSV1716 is active against triple negative breast cancer. Future Pharmacology, 2 (4). pp. 444-459. ISSN 2673-9879

Howard, F.H.N. orcid.org/0000-0001-9899-3079, Kwan, A., Winder, N. et al. (3 more authors) (2022) Understanding immune responses to viruses—do underlying Th1/Th2 cell biases predict outcome? Viruses, 14 (7). 1493.

Kwan, A., Winder, N. and Muthana, M. orcid.org/0000-0003-2497-8903 (2021) Oncolytic virotherapy treatment of breast cancer : barriers and recent advances. Viruses, 13 (6). 1128.

Newton, R., Carpenter, L., Casabonne, D. et al. (10 more authors) (2006) A Prospective Study of Kaposi's Sarcoma-Associated Herpesvirus and Epstein-Barr Virus in Adults With Human Immunodeficiency Virus-1. British Journal of Cancer, 94 (10). pp. 1504-1509. ISSN 0007-0920